Branched-chain amino acids and neurotransmitter metabolism: Expression of cytosolic branched-chain aminotransferase (BCATc) in the cerebellum and hippocampus

Authors

  • Andrew J. Sweatt,

    Corresponding author
    1. Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
    • Department of Biochemistry, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, North Carolina 27157
    Search for more papers by this author
  • Maria A. Garcia-Espinosa,

    1. Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
    Search for more papers by this author
  • Reidar Wallin,

    1. Department of Internal Medicine Section on Rheumatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
    Search for more papers by this author
  • Susan M. Hutson

    1. Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
    Search for more papers by this author

Abstract

In the brain, catabolism of the branched-chain amino acids (BCAAs) provides nitrogen for the synthesis of glutamate and glutamine. Glutamate is formed through transfer of an amino group from BCAA to α-ketoglutarate in reaction catalyzed by branched-chain aminotransferases (BCAT). There are two isozymes of BCAT: cytosolic BCATc, which is found in the nervous system, ovary, and placenta, and mitochondrial BCATm, which is found in all organs except rat liver. In cell culture systems, BCATc is found only in neurons and developing oligodendrocytes, whereas BCATm is the isoform in astroglia. In this study, we used immunohistochemistry to examine the distribution of BCATc in the rat brain, focusing on the well-known neural architecture of the cerebellum and hippocampus. We show that BCATc is expressed only in neurons in the adult rat brain. In glutamatergic neurons such as granule cells of the cerebellar cortex and of the dentate gyrus, BCATc is localized to axons and nerve terminals. In contrast, in GABAergic neurons such as cerebellar Purkinje cells and hippocampal pyramidal basket cells, BCATc is concentrated in cell bodies. A common function for BCATc in these neurotransmitter systems may be to modulate amounts of glutamate available either for release as neurotransmitter or for use as precursor for synthesis of GABA. Particularly striking in our findings is the strong expression of BCATc in the mossy fiber pathway of the hippocampal formation. This result is discussed in light of the effectiveness of the anticonvulsant drug gabapentin, which is a specific inhibitor of BCATc. J. Comp. Neurol. 477:360–370, 2004. © 2004 Wiley-Liss, Inc.

Ancillary